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Abstract 
Kir4.1/5.1 heterotetramer participates in generating the negative cell membrane potential in distal 
convoluted tubule (DCT) and plays a critical role in determining the activity of Na-Cl co-transporter (NCC). 
Kir5.1 contains a phosphothreonine-motif at its c-terminus (AA249-252). Co-immunoprecipitation showed 
that Nedd4-2 was associated with Kir5.1 in HEK293 cells cotransfected with Kir5.1 or Kir4.1/Kir5.1. GST-
pull-down further confirmed the association between Nedd4-2 and Kir5.1. Ubiquitination assay showed 
that Nedd4-2 increased the ubiquitination of Kir4.1/Kir5.1 heterotetramer in the cells co-transfected with 
Kir4.1/Kir5.1 but it has no effect on Kir4.1 or Kir5.1 alone. Patch-clamp and western blot also demonstrated 
that co-expression of Nedd4-2 but not Nedd4-1 decreased K currents and Kir4.1 expression in the cells 
cotransfected with Kir4.1 and Kir5.1. In contrast, Nedd4-2 fails to inhibit Kir4.1 in the absence of Kir5.1 
or in the cells transfected with the inactivated form of Nedd4-2 (Nedd4-2C821A). Moreover, the mutation 
of TPVT motif in the C-terminus of Kir5.1 largely abolished the association of Nedd4-2 with Kir5.1 and 
abolished the inhibitory effect of Nedd4-2 on K currents in HEK293 cells transfected with Kir4.1 and Kir5.1 
mutant (Kir5.1T249A). Finally, the basolateral K conductance in the DCT and Kir4.1 expression is 
significantly increased in the kidney-specific Nedd4-2 knockout or in Kir5.1 knockout mice in comparison 
to their corresponding WT littermates. We conclude that Nedd4-2 binds to Kir5.1 at phosphothreonine-
motif of the c-terminus and the association of Nedd4-2 with Kir5.1 facilitates the ubiquitination of Kir4.1 
thereby regulating its plasma expression in the DCT.  
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Introduction 
Kir4.1 (encoded by Kcnj10) is an inwardly-rectifying K channel which interacts with Kir5.1 (encoded by 
Kcnj16) to form a 40 pS K channel in the basolateral membrane of the distal convoluted tubule (DCT)(14; 
18; 28). Because this 40 pS K channel is the only type of K channel in the basolateral membrane of the 
DCT(28; 35), it plays a key role in generating negative membrane potential and handling K recycling. 
Previous studies have demonstrated that the deletion of Kir4.1 completely eliminated the basolateral K 
conductance and depolarized the membrane of the DCT (35).  Kir4.1/Kir5.1 channel activity in the DCT 
plays a key role in determining the expression of Na-Cl cotransporter (NCC) and in mediating the effect of 
dietary K intake on NCC through a Cl-sensitive with-no-lysine kinase (WNK) pathway (2; 4; 19; 35).  Since 
NCC plays a role not only in reabsorption of 5% of the filtered Na load but also in regulating renal K 
excretion (8; 16), the modulation of Kir4.1/5.1 channel activity should have a profound effect on renal Na 
and K handing(5).  
While Kir4.1 is a K-conductive component for the Kir4.1/5.1 heterotetramer (18) , the role of Kir5.1 in 
forming the heterotetramer is not completely understood. It has been demonstrated that Kir5.1 may regulate 
the pH sensitivity of the basolateral K channels in the DCT (17; 18). The analysis of Kir5.1 amino acid 
sequence reveals that Kir5.1 contains a phosphothreonine-motif (TPVT) at its c-terminus (AA249-252) 
which has been shown to bind to E3 ubiquitin ligase Nedd-4 (15). The main isoform of Nedd4-2 E3 ligase 
in the aldosterone-sensitive distal nephron is Nedd4-2(21). Nedd4-2 is a HECT-domain containing E3 
ligase and plays a profound role in regulating ubiquitination of a variety of ion transporters, such as NCC 
and ENaC (21; 22; 36).  Nedd4-2 contains a C2 domain and four WW domains which confer protein 
interaction with the substrate protein.  Nedd4-2 selects and recruits the substrate protein not only by binding 
to canonical PY motif of the substrate protein through its specific WW domain but also to phospho-
threonine/serine motif (1; 15). This study is aimed at exploring whether Kir5.1 is a binding component for 
Nedd4-2 thereby regulating Kir4.1 ubiquitination in the DCT.  
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Methods 
Animals      We used Kcnj16+/+ (Kir5.1 WT), Kcnj16-/- (Kir5.1 knockout) mice with C57bl/6 background, 
inducible kidney-specific Nedd4-2 deletion (Ks-Nedd4-2 KO) and Nedd4lflox/flox (WT control for Ks-Nedd4-
2 KO) mice with C57bl/6 background for the experiments. We have purchased male and female Kcnj16+/- 
mice from Mary Lyon Center (Oxfordshire, UK) for breeding in the animal facility of New York Medical 
College. After genotyping, we used both 8 week-old male or female Kcnj16-/- and Kcnj16+/+ mice for 
experiments. To generate Ks-Nedd4-2 KO mice, mice expressing Pax8-rtTA and tet-on LC-1 transgene 
were crossed with Nedd4lflox/flox mice which were originally generated in O. Staub’s laboratory (22). Nedd4l 
deletion was carried out in 8-week-old male and/or female mice homozygous for floxed Nedd4l gene and 
heterozygous for Pax8-rtTA/LC-1 transgene by providing doxycycline (5mg/ml, 5% sucrose) in the 
drinking water for 2 weeks. This was followed by at least 2 additional weeks without doxycycline treatment 
before performing experiments. Littermate mice of the same age and genetic background and drinking 5% 
sucrose were used as controls (Nedd4lflox/flox). Genotyping confirms the positive strain Nedd4-2cre-flox. 
The primers for genotyping were listed in Table 1. All the procedures were reviewed and approved by the 
Institutional Animal Care and Use Committee (IACUC).  
Preparation of the DCT     Mice were sacrificed by cervical dislocation and the abdomen was opened to 
expose the left kidney. We perfused the left kidney with 2 ml L-15 medium (Life Technology) containing 
Type 2 collagenase (250 U/ml) and then removed the collagenase-perfused kidney. The renal cortex was 
separated and further cut into small pieces for additional incubation in collagenase-containing L-15 media 
for 30-50 min at 37oC. The tissue was then washed three times with fresh L-15 medium and transferred to 
an ice-cold chamber for dissection. The isolated DCT tubules were placed on a small cover glass coated 
with poly-lysine and the cover glass was placed on a chamber mounted on an inverted microscope.  
Cell culture and Gene Transfection      HEK293 cells (ATCC, Manassas, VA) were used for transient 
expression of Kir4.1, Kir5.1 and Nedd4-1 or Nedd4-2. The cells were grown in Dulbecco's modified Eagle 
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medium (DMEM; Invitrogen) supplemented with 10% FBS (Invitrogen) in 5% CO2 and 95% air at 37oC. 
Cells were grown to 50–70% confluence for transfection as described previously (34). Briefly, a cDNA 
cocktail (total 2 µg) was prepared with 200 µl serum free DMEM and 6 µl Turbofect transfection reagent 
(Thermo Fisher Scientific) for the cells in a 35 mm dish. Cells transfected with the empty vector were used 
as  IgG control for immunoprecipitation (IP) and their background currents were subtracted from that of 
the experimental groups for patch-clamp study. After 15 min incubation at room temperature, the mixture 
of the transfection cocktail was applied to the cells followed by additional 24 h incubation before use.  
Co-immunoprecipitation (CO-IP) and Ubiquitination assay         IP was performed as previously 
described(13). Briefly, 200 µg total protein was mixed with 2 µg of the IP antibody in 200 µl of 1% PBST. 
The mixture was incubated with overnight shaking at 4°C and followed by adding 50 µl of protein A agarose 
(Santa Cruz Biotechnology, Dallas, TX) and mixing gently with shaking for an additional hour. The agarose 
was pelleted and ready for SDS-PAGE gel examination.  
For the ubiquitination assay, 2% SDS was added into 200 µg total protein lysate. The sample was incubated 
for 5 min at 95°C and diluted 10 times with lysate buffer before conducting immunoprecipitation (IP). The 
IP antibody was added into the lysate as in the protocol described above.  
Site-directed mutagenesis         The over-lapping PCR-based mutagenesis method was used to generate 
Kir5.1 mutants (UniProtKB-Q9NPI9-Human). Two pairs of complementary primers harboring the mutant 
site Kir5.1T249A or –T249D were phosphorylated by T4 polynucleotide kinase at 37 °C. We used 20 ng 
of pcDNA3-Flag-Kir5.1 as template. A 50 µl PCR reaction was set up routinely, including with LA-Taq 
and DNA ligase. After PCR product was incubated with DpnI for 1 h, 1 µl PCR product was used for 
transformation. Mutant plasmid DNA was verified by sequencing.  
Whole cell recording with patch clamp        Borosilicate glass (1.7-mm OD) (Harvard Apparatus, Holliston, 
MA USA) was used to make the patch-clamp pipettes that were pulled with a Narishige electrode puller 
(Narishige, Long Island, NY, USA). The pipette had a resistance of 2 to 4 MΩ when filled with 140 mM 
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KCl. The tip of the pipette was filled with pipette solution containing 140 mM KCl, 2 mM MgCl2, 1 mM 
EGTA, and 5 mM HEPES (titrated with KOH, pH=7.4). The pipette was then back-filled with pipette 
solution containing amphotericin B (20 μg/0.1 mL). For measurement of Ba2+-sensitive K currents, the cells 
were incubated with a bath solution containing 140 mM KCl, 2 mM MgCl2, 1.5 mM CaCl2, and 5 mM 
HEPES (titrated with KOH, pH=7.4). After forming a high-resistance seal (>2 GΩ), the membrane 
capacitance was monitored until the whole-cell patch configuration was formed. The cell membrane 
capacitance was measured and compensated. This compensated value indicated the membrane capacitance 
of each cell and it was used for normalizing K currents for each measurement. K currents were measured 
by an Axon 200A patch-clamp amplifier (Molecular Devices, Sunnyvale, CA, USA). The currents were 
low-pass filtered at 1 KHz and digitized by an Axon interface (Digidata 1320, Molecular Devices). Data 
were stored in a Dell PC and analyzed using the pClamp software version 9 at sampling rate of 4K Hz 
(Molecular Devices). K current measured in HEK cells was presented as picoamperes (pA)/30 picofarads 
(pF) while it was pA per DCT cell. 
GST pull down           Four WW domains of Nedd4-2 and full length of Kir5.1 were individually inserted 
into pGEX4T-1 vector. C-terminal of Kir5.1 was inserted into pET19b vector. The primers used for the 
procedures were listed in Table 2. The constructs were confirmed by sequencing.  For the induction of 
expression, 10 ml BL21 E. coli containing the transformed plasmid pGEX4T-1-WW domain proteins or 
pET19b-Kir5.1-C-terminus were induced by IPTG (0.2 mM) for 4-5 hr. Cell pellets were lysed with 
BugBuster protein extraction buffer (EMD Millipore, Billerica, MA). Supernatant was taken after 
centrifuging. Total protein concentration was quantified. 200 µg total GST protein was mixed with 50 µl 
of washed Glutathione beads (Thermo Fisher Scientific). After shaking at 4 °C for 2 h, we added 200 µg 
total protein containing flag-tagged-Nedd4-2 obtained from TNT T7 Quick Coupled Translation System 
(Promega, Madison, WI) into GST-proteins for overnight incubation.  The mixture was washed three times 
with 1% PBST and the beads were loaded to PAGE-SDS gel. 
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Immunofluorescent staining             Mice were anesthetized and perfused with 30 mL PBS containing 
heparin (40 unit/mL) followed by 100 mL of 4% paraformaldehyde. After perfusion, the kidneys were 
embedded and cut into 7 μm slices with Leica1900 cryostat (Leica). The slides were washed with 1× PBS 
for 15 min, and permeabilized with 1× PBS buffer containing 0.3% Triton X100, 1% BSA and 0.1% lysine 
(pH = 7.4) for 15 min. Kidney slices were blocked and incubated with primary antibodies (Kir4.1) for 24 h 
at 4 °C. Immunostaining was examined with Olympus inverted microscope DP73.  
Antibodies and reagents           We purchased primary antibodies for HA and Ub4D1 from Covance 
(Dedham, MA), for Nedd4-2 from Cell Signaling Technologies (Beverly, MA, USA), for monoclonal Flag 
from Sigma, for Kir4.1 and Kir5.1 from Alomone Labs (APC-123) (Jerusalem, Israel). We also obtained 
Kir5.1 antibody (repeat and validate the results from APC-123) from Santa Cruz Biotechnology (SC-30151) 
(Dallas, TX) and α-Tubulin and GFP from Rockland (Limerick, PA). We purchased second antibodies 
including IRDye® 800CW Goat anti-Mouse IgG, IRDye® 680RD Goat anti-Rabbit IgG from LI-COR. All 
antibodies were validated by using corresponding genetic modified animals (for Kir4.1 and Kir5.1) or 
previous experimental information.  All chemicals and proteinase/phosphatase inhibitors were purchased 
from Sigma Aldrich (St. Louis, MO) unless otherwise specified.  
Statistics analysis          Student’s t-test (unpaired groups) was used to determine the significance of 
differences between two groups or one-way analyses of variance (ANOVA) was used to determine the 
statistical significance among multiple groups. Holm-Sidak was used as post hoc test. P<0.05 was defined 
as statistical significance. 
Results 
Kir5.1 interacts with Nedd4-2.             We first examined the interaction between Kir5.1 and Nedd4-2 with 
CO-IP in HEK293 cells transfected with HA-GFP-tagged Kir5.1 and Flag-tagged Nedd4-1 or Nedd4-2. We 
used Flag antibody (precipitating either Nedd4-2 or Nedd4-1) for IP and HA antibody (detecting Kir5.1) 
for blotting. Fig.1A shows that Nedd4-2/Kir5.1 interaction (top panel)  was stronger than Nedd4-1/Kir5.1 
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interaction , suggesting that Kir5.1 is mainly associated with Nedd4-2. Fig.1A also shows equal expression 
of Flag-tagged Nedd4-2 or Nedd4-1(middle panel) and HA-GFP tagged Kir5.1 (lower panel). We next 
conducted CO-IP with myc antibody in the cells transfected with myc-his-tagged Kir5.1 and Flag-Nedd4-
2 or –Nedd4-1. Fig.1B is a western blot showing that myc-Kir5.1 was predominantly associated with 
Nedd4-2. After demonstrating that Kir5.1 was able to bind to Nedd4-2, we next examined the binding site 
of Kir5.1 with Nedd4-2. Although Kir5.1 has no typical PY motif, it has a phosphothreonine motif in the 
c-terminus (TPVT from amino acid sequence 249-252) which has been shown to be a binding site for Nedd4 
in M-phase inducer phosphatase 3 (15).  To test the possibility, we conducted CO-IP with flag antibody in 
the cells transfected with Kir5.1T249A in which threonine was mutated to alanine. As shown in Fig. 1C (top 
panel), the mutation (Kir5.1T249A ) decreased the binding of Kir5.1 with Nedd4-2. From 4 separate 
experiments it is calculated that T249A mutation significantly decreased the association between 
Kir5.1/Nedd4-2 from WT control 1.10±0.15 (normalized band density) to 0.50±0.24 (Fig.1E). In contrast, 
mutating Thr249 into Aspartate (D) slightly enhanced association (band density=1.36±0.10) although this 
was not significantly different from (Kir5.1) control (1.10±0.15) (Fig.1E). In contrast, the mutation of Thr252 
to either Ala (1.07±0.11) or Asp (1.18±0.09) did not significantly affect the interaction between Kir5.1 and 
Nedd4-2 (Fig.1D). Thus, the results suggest that TPVT motif of Kir5.1 is a binding site for Nedd4-2. 
To further test for the interaction between Nedd4-2 and Kir5.1 in vitro, we conducted GST pull-down 
experiments using purified GST fusion proteins from prokaryotic cells.  From the inspection of Fig.2A, it 
is apparent that full-length GST-tagged Kir5.1 protein binds to Flag-tagged Nedd4-2 while GST protein 
failed to pull down Nedd4-2. Moreover, GST-pull-down experiments using Nedd4-2 WW domain peptide 
showed that the second WW domain of Nedd4-2 (2nd WW) is critical for binding to Kir5.1 (Fig.2B) 
comparing with the other three WW domains of Nedd4-2. Fig. 2B is a bar graph showing the normalized 
bands density ratio calculated from three separate pull-down experiments demonstrating that the second 
WW domain serves as the main binding site for Kir5.1. The calculated ratio was  1.00±0.07 (1st WW) , 
11.64±0.93 (2nd WW),  0.73±0.02 (3rd WW) and 1.30±0.02 (4th WW), respectively (mean±SD p<0.01 for 
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2nd WW : 1st WW, 3nd WW or 4th WW). Thus, our experiments strongly suggest that Nedd4-2 is a binding 
partner for Kir5.1 or Kir4.1/Kir5.1 and that the second WW domain of Nedd4-2 is a major binding site for 
Kir5.1. 
Ubiquitination of Kir4.1 by Nedd4-2 requires Kir5.1.                Having demonstrated the interaction between 
Nedd4-2 and Kir5.1, we further examined whether Nedd4-2 is able to ubiquitinate Kir5.1 or Kir4.1/5.1. 
Thus, we conducted ubiquitination assay using HEK293 transfected with Flag-Kir4.1/myc-Kir5.1/HA-
Nedd4-2 or Flag-Kir5.1/myc-Kir4.1/HA-Nedd4-2. We used Flag antibody for immunoprecipitating Kir4.1 
or Kir5.1 and Ub4D1 antibody for detecting ubiquitinated K channels. Fig.3A is a typical Western blot 
from five similar experiments showing that Nedd4-2 was not able to ubiquitinate Kir4.1 or Kir5.1 but it 
stimulated the ubiquitination of Kir4.1/Kir5.1 heterotetramer. Considering that Kir5.1 binds to Nedd4-2, 
we suspected that Nedd4-2 ubiquitinates Kir4.1 only in the presence of Kir5.1. This notion was also 
suggested by ubiquitination assay of Kir4.1 using denatured IP (same procedure described in Fig. 3A except 
for the pretreatment with 2% SDS before adding Flag antibody for IP). Fig. 3B is a representative western 
blot from three separate IP showing that Nedd4-2 enhanced Kir4.1 ubiquitination in the presence of Kir5.1. 
Slightly increased ubiquitination with Kir4.1/Kir5.1, Kir5.1/Nedd4-2 and 4.1/Nedd4-2 may be due to some 
endogenous proteins involving in ubiquitination. Since Kir4.1 is responsible for forming the K-conductive 
pathway of Kir4.1/5.1 (18), Nedd4-2-induced ubiquitination of Kir4.1/5.1 is expected to inhibit K channel 
activity. Thus, we next examined the effect of Nedd4-2 on Kir4.1 using the whole-cell recording in HEK293 
cells transfected with GFP/HA-tagged Kir4.1 and Kir5.1 in the presence or absence of Nedd4-2. Twenty-
four hours after transfection, GFP-positive cells were selected for the patch-clamp experiments. The cells 
were bathed with symmetrical 145 mM K solution (140 mM KCl and 5 M KOH) and the Ba2+ –sensitive K 
currents were measured with step protocol from -60 mV to 60 mV at 20 mV step. Fig.4A and 4B are two 
recordings showing Ba2+-sensitive K currents in the cells transfected with Kir4.1+Kir5.1 and Nedd4-
2+Kir4.1/5.1 respectively. Results from six experiments are summarized in Fig.4C showing that Nedd4-2 
inhibits Kir4.1/5.1 channels and significantly decreased Ba2+-sensitive K currents from 9300±290 pA to 
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5600±110 pA. The effect of Nedd4-2 on Kir4.1 was specific because co-expression of Kir5.1 and Nedd4-
1 did not reduce Kir4.1 activity (9030±160 pA). In addition, dominant-negative Nedd4-2 (Nedd4-2DN, 
Nedd4-2C821A), an enzyme-inactivated form of Nedd4-2, failed to inhibit Kir4.1/5.1 (9250±290 pA) (Fig. 
4C).  
Having demonstrated that Nedd4-2 but not Nedd4-1decreases Kir4.1/5.1 K currents, we next used western 
blot to examine whether the inhibitory effect of Nedd4-2 on Kir4.1/5.1 was due to decreasing the expression 
of Kir4.1. Fig.5A is a western blot showing the expression of Kir4.1 in the cells transfected with 
Kir4.1+Nedd4-2, Kir4.1/5.1+Nedd4-2, Kir4.1+Nedd4-1 and Kir4.1/5.1+Nedd4-1. Fig. 5B is a bar graph 
showing the normalized band density of Kir4.1 expression which was reduced by the coexpression of Kir5.1 
and Nedd4-2. While the expression of Kir4.1 in the cells transfected with Kir4.1 alone was similar to those 
with Kir4.1+Nedd4-2 (data not shown), Nedd4-2 decreased Kir4.1 expression by 55±10% (n=4) in 
comparison to the control (Kir4.1+Nedd4-2). In contrast, Nedd4-1 had no effect on the expression of Kir4.1. 
Thus, the results from western blots are consistent with electrophysiological results supporting the notion 
that the inhibitory effect of Nedd4-2 on Kir4.1 requires Kir5.1. Since TPVT motif on Kir5.1 is critical for 
interacting with Nedd4-2, we next studied the role of TPVT motif of Kir5.1 in Nedd4-2-mediated 
Kir4.1inhibition using patch-clamp technique in HEK293 cells transfected with Kir4.1/Nedd4-2/Kir5.1 or 
Kir5.1 mutants. Results of 6 experiments are summarized in Fig. 5C showing that the expression of 
Kir5.1T249A largely abolished the inhibitory effect of Nedd4-2 on Kir4.1 (Kir4.1/5.1, 9330±250 pA; 
Kir4.1/5.1+Nedd4-2, 5500±170 pA; Kir4.1/5.1T249A + Nedd4-2, 8600±270 pA). However, the expression 
of Kir5.1T249D restored Nedd4-2-induced inhibition of Kir4.1 (5200±280 pA) while Ba2+-sensitive K 
currents in cells transfected with Kir4.1/5.1T249A  (9100±200 pA) or Kir4.1/5.1T249D (9000±270 pA) were 
similar to Kir4.1/5.1 (Fig.5D). This indicates that TPVT motif of Kir5.1 is important for Nedd4-2-induced 
Kir4.1 inhibition. 
Deletion of Kir5.1 increases Kir4.1 currents and expression in DCT.                    After demonstrating that 
Kir5.1 plays a key role in mediating the inhibitory effect of Nedd4-2 on the Kir4.1 channel activity in 
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HEK293 cells, we next examined the role of Kir5.1 in the regulation of Kir4.1 in vivo. It is well established 
that Kir5.1 interacts with Kir4.1 to form a 40 pS inwardly rectifying K channel in the basolateral membrane 
of the DCT (18). Since the 40 pS K channel is the only type of K channel in the early part of the DCT 
(DCT1), the whole-cell K currents in DCT1 are equal to Kir4.1 which is responsible for forming K 
conductive pathway of Kir4.1/5.1 heterotetramer. Fig.6A is a trace of Ba2+-sensitive K currents measured 
with RAMP protocol from -100 to 100 mV in DCT1 of WT and Kir5.1-/- mice (Kir5.1KO). It is apparent 
that whole-cell K currents in the DCT1 of Kir5.1-/- mice are larger than those of WT mice. The results from 
seven experiments are summarized in Fig. 6B showing that Ba2+–sensitive K+ currents measured at -60 mV 
were 1300±100 pA (WT) and 2200±280 pA ( Kir5.1-/-), respectively. Since the DCT K currents were 
measured at DCT1 where no ROMK activity was detected, therefore, the whole-cell K currents represent 
Kir4.1 activity(28; 34). Thus, the deletion of Kir5.1 significantly augments the basolateral Kir4.1 activity. 
This notion was also supported by immunoblotting to examine Kir4.1 expression in the kidney from Kir5.1-
/- mice and the WT littermates. Fig. 6C is a western blot showing that the expression of Kir4.1 increased by 
100±11% in Kir5.1-/- mice comparing with WT littermates (normalized with β-actin) (Fig. 6D). We also 
conducted immunofluorescent staining to examine the expression of Kir4.1 in the kidney from both WT 
and Kir5.1-/- mice. From inspection of Fig.6E, it is apparent that the fluorescence intensity of Kir4.1 staining 
is more intensified in Kir5.1-/- mice than WT littermates. Thus, electrophysiology, western blotting and 
immunostaining show that the deletion of Kir5.1 stimulates Kir4.1currents and expression in the DCT. 
Deletion of Nedd4-2 increases Kir4.1currents and activity in DCT.          If the deletion of Kir5.1-induced 
increase in Kir4.1 activity in the DCT depends on Nedd4-2 activity, we speculate that deletion of Nedd4-2 
should mimic the effect of Kir5.1 deletion and increase Kir4.1 activity in the DCT. Thus, we used patch-
clamp technique (Fig.7A), western blot (Fig.7B) and immunostaining (Fig.7C) to examine Kir4.1 in WT 
and kidney-specific Nedd4-2 knockout mice (Ks-Nedd4-2KO). Ks-Nedd4-2 KO mice were generated by 
doxycycline-treatment for two weeks and western blot shows that Nedd4-2 expression was completely 
eliminated in doxycycline-treated mice while it was present in untreated (control) mice. Fig. 7A summarizes 
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the result of 6 experiments in which the Ba2+-sensitive K currents were measured in the DCT of WT and 
Ks-Nedd4-2 KO mice with the whole cell-recording. We observed that the whole-cell K currents measured 
at -60 mV was 1270±150 pA (WT mice) and 1980±250 pA (Ks-Nedd4-2 KO mice), respectively. Having 
shown that deletion of Nedd4-2 increased Kir4.1 currents in the DCT, we then examined the expression of 
Kir4.1 and Kir5.1 by western blot in WT and Ks-Nedd4-2 KO mice (Fig. 7B). It is apparent that the 
depletion of Nedd4-2 significantly increases the expression of Kir4.1 by 90±10% (n=4) but it did not 
significantly change the expression of Kir5.1 in comparing with WT control. In addition, we carried out 
immunostaining to examine Kir4.1 expression in Ks-Nedd4-2 KO mice and WT littermates (Fig.7C). It 
shows that the staining of Kir4.1 is increased in Ks-Nedd4-2 KO mice comparing with WT littermates. 
Thus, deletion of Nedd4-2 stimulates Kir4.1 expression and augments the basolateral K conductance of the 
DCT. 
Discussion 
The main finding of the present study is that Nedd4-2 ubiquitinates Kir4.1/5.1 heterotetramer and decreases 
Kir4.1 currents in the presence of Kir5.1. A similar study has been reported. Ekberg et all have reported 
that C-terminal region of the KCNQ3 subunit is required for the Nedd4-2-mediated ubiquitination of 
voltage-gated K(+) channels KCNQ2/3 and KCNQ3/5 (7). Two lines of evidence suggest that Kir5.1 is a 
binding partner of Nedd4-2: 1) CO-IP experiments showed that Nedd4-2 was immunoprecipitated with 
Kir5.1; 2) GST pull-down experiments demonstrated that Nedd4-2 was associated with Kir5.1. Since Kir5.1 
is known to interact with Kir4.1 (18), it is possible that Kir5.1 plays a role in regulating the ubiquitination 
of Kir4.1/Kir5.1 by Nedd4-2. Nedd4-2 encoded by Nedd4l gene is a member of Nedd4 E3 ubiquitin ligase 
(21). Nedd4-2 has four WW domains which interact with PY motif or phosphor-serine or threonine-based 
motif of the substrate proteins and facilitates their ubiquitination and degradation (11; 15; 27). A large body 
of evidence has demonstrated that Nedd4-2 regulates the ubiquitination of ENaC through the interaction of 
PY motif in the β- and γENaC subunits with WW domains of Nedd4-2 (6; 11; 24; 26). Although Kir5.1 
lacks a typical PY motif, it contains a TPVT motif at its c-terminus (AA 249 to 252). This motif is a 
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phosphothreonine-based binding motif of Nedd4 which has been shown to interact with M-phase inducer 
phosphatase 3 encoded by Cdc25c (15) and it is also highly preserved in Kir5.1 from humans, rats to mice. 
The observation that the expression of Kir5.1T249A largely attenuated while the expression of Kir5.1T249D 
enhanced the association between Kir5.1 and Nedd4-2 strongly suggests the critical role of TPVT sequence 
in the interaction between Nedd4-2 and Kir5.1. Moreover, the results from GST-pull-down further confirm 
that the second WW domain of Nedd4-2 is a major binding site for Kir5.1-Nedd4-2 association. Also, the 
observation that Nedd4-1 failed to mimic the effect of Nedd4-2 on Kir4.1 suggests that Nedd4-2 is the E3 
ubiquitin ligase regulating Kir4.1/Kir5.1. 
Although Nedd4-2 binds to Kir5.1, it is unlikely that Nedd4-2 facilitates the ubiquitination of Kir5.1 protein 
since coexpression of Nedd4-2 and Kir5.1 failed to change Kir5.1 ubiquitination. This notion is also 
supported by the finding that the deletion of Nedd4-2 had no effect on Kir5.1 expression in the kidney. 
Several lines of evidence suggest that the interaction of Nedd4-2 with Kir5.1 plays a key role in regulating 
Kir4.1 activity by ubiquitination. First, Nedd4-2 stimulates the ubiquitination of Kir4.1/Kir5.1 while it had 
no effect on Kir4.1 ubiquitination in the absence of Kir5.1.  Second, Nedd4-2 decreases Kir4.1 expression 
and Kir4.1 currents only in the presence of Kir5.1. Third, deletion of either Kir5.1 or Nedd4-2 stimulates 
the basolateral K conductance and increases Kir4.1 expression in the native DCT. Our observation that the 
deletion of Kir5.1 increased the basolateral K conductance in the DCT is consistent with the report that 
Kir5.1−/− mice displayed an increased basolateral K channel activity in the DCT(17). Although it is possible 
that reduced pH-sensitive may also contribute to the stimulation of Kir4.1 activity in Kir5.1-/- mice, the 
observation that Kir5.1T249A abolished the inhibition effect of Nedd4-2 on Kir4.1 implies that Kir5.1/Nedd4-
2 interaction plays a role in regulating Kir4.1. This notion was also strongly supported by the observation 
that basolateral K conductance and Kir4.1 expression were increased in the DCT of Ks-Nedd4-2 KO mice. 
Fig. 8 is a scheme illustrating the mechanism by which Nedd4-2 interaction with Kir5.1 regulates Kir4.1. 
Nedd4-2 binds to TPVT motif of Kir5.1 thereby facilitating the ubiquitination of Kir4.1. The model of 
recognition in trans via an ancillary protein in ubiquitination system has been previously studied (7; 9). The 
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ubiquitinated Kir4.1 is expected to be endocytosed and degraded thereby decreasing the basolateral K 
channels in the DCT. The finding that deletion of Nedd4-2 did not alter the Kir5.1 expression suggests the 
possibility that Kir5.1 could be recycled and reused in forming Kir4.1/Kir5.1 heterotetramer. Thus, the 
inhibitory effect of Nedd4-2 on Kir4.1 mainly depends on the interaction between Nedd4-2 and Kir5.1. 
Kir4.1 is expressed in the basolateral membrane of the late thick ascending limb (TAL), the DCT, 
connecting tubule (CNT) and cortical collecting duct (CCD)(4; 29; 33). Although Kir4.1 can form a low 
conductance (12-20 pS) homotetramer K channel in the absence of Kir5.1 (17; 18), it is well-documented 
that under physiological conditions, Kir4.1 interacts with Kir5.1 to form a 40 pS inwardly-rectifying K 
channel expressed in the basolateral membrane of TAL, DCT, CNT and CCD(3; 4; 12; 14). However, 
unlike in the TAL and in the CCD, this 40 pS K channel is the only type of K channel in the basolateral 
membrane of the DCT and plays a key role in generating negative membrane potential and K recycling(4; 
34). Our previous experiments have demonstrated that Kir4.1 plays a dominant role in determining the 
basolateral K conductance in the DCT because disruption of Kir4.1 almost completely eliminates 
basolateral K conductance(4).  
The physiological significance of our finding is to illustrate the role of Kir5.1 and Nedd4-2 interaction in 
regulating the basolateral Kir4.1 conductance of the DCT. DCT is responsible for reabsorption of 5% of 
the filtered sodium load and plays a key role in regulating renal K excretion in the aldosterone-sensitive 
distal nephron (ASDN) (8; 16). Recently, a large body of evidence suggests that thiazide-sensitive Na-Cl 
cotransporter (NCC) plays a key role in regulating renal K excretion (20; 23; 25; 31). For instance, 
hyperkalemia-induced decrease in NCC activity should increase sodium and volume delivery to the latter 
part of ASDN thereby stimulating K excretion. Conversely, hypokalemia-induced stimulation of NCC 
activity should decrease sodium and volume delivery to the ASDN thereby inhibiting K excretion in ASDN. 
Thus, the regulation of NCC is important for proper regulation of renal K excretion and K homeostasis. A 
high NCC activity has been shown to be related to Familial Hyperkalemic Hypertension while a low NCC 
activity has been demonstrated to be responsible for hypokalemia in Gitelman’s syndrome (10; 23; 30). Our 
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previous study has demonstrated that Kir4.1 plays a key role in mediating the effect of dietary K intake on 
NCC activity (32). We have demonstrated that hyperkalemia-induced inhibition of the basolateral Kir4.1 is 
essential for the down-regulation of NCC while hypokalemia-induced stimulation of the basolateral Kir4.1 
plays a critical role in stimulating NCC(32). It is most likely Cl-sensitive With-No-Lysine kinase (WNK) 
links the basolateral Kir4.1 activity to apical NCC activity (2; 19). Because Kir4.1 plays a role in regulating 
NCC, it is conceivable that Kir5.1 and Nedd4-2 interaction may play an important role in mediating the 
effect of dietary K intake on the basolateral K conductance in the DCT. This notion is supported by the 
report that NCC activity is upregulated in Kir5.1 KO mice and Ks-Nedd4-2 KO mice (17; 22). Our study 
also raises the possibility whether dietary K intake may also regulate the expression of Nedd4-2 thereby 
affecting NCC. However, further experiments are needed to explore this possibility. Thus, the modulation 
of Kir4.1 mediated by Nedd4-2/Kir5.1 interaction should expand our understanding the mechanism by 
which Kir4.1 regulates NCC function and K excretion. We conclude that Nedd4-2 ubiquitinates Kir4.1 
through binding to Kir5.1 at TPVT motif and that the interaction between Kir5.1 and Nedd4-2 regulates 
basolateral Kir4.1 channel activity in DCT.  
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Figure legends 
Fig. 1 Nedd4-2 interacts with Kir5.1. (A) Co-immunoprecipitation experiments (Co-IP) show the 
interaction of Kir5.1 with Nedd4-2 or Nedd4-1 in HEK293 cells transfected with HA-GFP-Kir5.1 and Flag-
tagged Nedd4-2 or Nedd4-1 (top panel). Middle panel shows the equal amount of Flag-Nedd4-2 and –
Nedd4-1 used for Co-IP. Lower panel shows the input of HA-GFP-Kir5.1. (B) Co-IP shows the interaction 
of Nedd4-2 or Nedd4-1 with Kir5.1 in HEK293 cells transfected with myc-Kir5.1 and Flag-tagged-Nedd4-
2. Lower panel shows the equal amount of myc-Kir5.1 used for Co-IP. An unspecific band is indicated by 
a star. Cells transfected with myc-Kir5.1 are used as negative control (Labelled as Kir5.1). (C) Co-IP shows 
that interaction of Nedd4-2 and Kir5.1/mutants in HEK293 cells transfected with Flag-tagged-Nedd4-2 and 
HA-GFP-Kir5.1 or mutants (Kir5.1T249A or Kir5.1T249D) (Top panel). Middle panel shows the equal amount 
of Flag-Nedd4-2 and –Nedd4-1 used for Co-IP. Lower panel shows the input of HA-GFP-Kir5.1. Cells 
transfected with empty vector are used as IgG control (labelled as IgG). Cells transfected with Flag-Nedd4-
2 are used as negative control (Labelled as Nedd4-2). (D) Co-IP shows that interaction of Nedd4-2 and 
Kir5.1/mutants in HEK293 cells transfected with Flag-tagged-Nedd4-2 and HA-GFP-Kir5.1 or mutants 
(Kir5.1T252A or Kir5.1T252D) (Top panel). Middle panel shows the  amount of Flag-Nedd4-2 used for Co-IP. 
Lower panel shows the input of HA-GFP-Kir5.1. (E) A bar graph illustrates the normalized band density 
for the results of CO-IP. 
Fig. 2 The second WW domain of Nedd4-2 interacts with Kir5.1. (A) Glutathione agarose gel shows 
that flag-tagged Nedd4-2 is pulled down by GST-Kir5.1 (Top panel).  GST-Kir5.1 and GST are indicated 
in middle panel and lower panel shows the input of Flag-tagged-Nedd4-2. Flag-Nedd4-2 (200µg) obtained 
from TNT T7 Quick Coupled Translation System was added for the experiments. GST protein was mixed 
with 50 µl of washed Glutathione beads. (B) GST-pull-down experiments using Nedd4-2-WW domain 
peptide show that His-Kir5.1-C-terminus containing TPVT motif (AA 249 to 252) prefers to interact with 
Nedd4-2 2nd WW domain peptide.  Each of four WW domains of Nedd4-2 (Table 2) was cloned into 
pGEX4T-1 vector by PCR. A bar graph summarizing the above results is shown in the bottom panel.  
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Fig. 3 Kir 5.1 is required for Nedd4-2-mediated ubiquitination of Kir4.1. (A) Ubiquitination assay 
shows ubiquitinated K channel in HEK293 cells transfected with flag-tagged Kir4.1 or Kir5.1, 
Kir4.1+Nedd4-2, Kir4.1+Kir5.1, Kir5.1+Nedd4-2 and Kir4.1/5.1+ Nedd4-2, respectively. Flag antibody 
was used to immunoprecipitate Flag-tagged Kir4.1 or 5.1 and ubiquitin (Ub) antibody was used to detect 
ubiquitinated K channels (indicated by a bracket). (B) Ubiquitination assay with SDS pretreatment shows 
ubiquitinated K channels in HEK293 cells transfected with Flag-tagged Kir4.1, Kir4.1+Nedd4-2 and 
Kir4.1/5.1+Nedd4-2. Lower panel shows the expression of Kir4.1 used for IP. 
Fig.4 Nedd4-2 but not Nedd4-1 inhibits Kir4.1/Kir5.1 channels. Whole-cell recording shows Ba2+-
sensitive K currents measured from -60 mV to 60 mV at -20 mV step in HEK293 cells transfected with 
Kir4.1+Kir5.1 (A) or with Kir4.1/5.1 +Nedd4-2 (B). The symmetrical 145 mM K solution was used for 
both bath and pipette.  (C) A bar graph summarizes the results of experiments (n=6) in which Ba2+-sensitive 
K currents were measured with whole-cell recording in HEK293 cells transfected with Kir4.1, 
Kir4.1+Nedd4-2, Kir4.1/5.1, Kir4.1/5.1+Nedd4-2, Kir4.1/5.1+Nedd4-1 and Kir4.1/5.1+dead Nedd4-2. The 
patch-clamp experiments were performed 24 hr after the transfection and the positive transfected cells were 
identified by GFP fluorescence.  
Fig.5 Mutation of TPVT motif of Kir5.1 abolishes Nedd4-2-mediated inhibition of Kir4.1/5.1. (A) A 
western blot shows the expression of Kir4.1 in HEK293 cells transfected with Ki4.1+Nedd4-2, 
Kir4.1/5.1+Nedd4-2, Kir4.1+Nedd4-1 and Kir4.1/5.1+Nedd4-1. The expression of Nedd4 was shown in 
the middle panel. (B) The normalized band density of Kir4.1 expression is shown in a bar graph. (C) A bar 
graph summarizes the results of experiments in which Ba2+-sensitive K currents were measured (at -60 mV) 
with whole-cell recording in HEK293 cells transfected with Kir4.1/5.1, Kir4.1/5.1+Nedd4-2, 
Kir4.1/5.1T249A+Nedd4-2 and Kir4.1/5.1T249D +Nedd4-2, respectively (n=6). (D) Ba2+-sensitive K currents 
measured at -60 mV with whole-cell recording in HEK293 cells transfected with Kir4.1/5.1, Kir4.1/5.1T249A 
and Kir4.1/5.1T249D (n=6).  The patch-clamp experiments were performed 24 hr after the transfection and 
symmetrical 145 mM K was used for the pipette and the bath solution.  
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Fig. 6 Deletion of Kir5.1 stimulates the basolateral Kir4.1 in the DCT. (A) A whole-cell recording 
showing Ba2+-sensitive K currents in the DCT of the WT or Kir5.1 KO mice. The K currents were measured 
with a ramp protocol from -100 to 100 mV using symmetrical 145 mM K solution in the bath and pipette. 
(B) A bar graph summarizes the results of experiments in which Ba2+-sensitive K currents of the DCT were 
measured at -60 mV from the WT and Kir5.1 KO mice (n=6). Western blot shows the expression of Kir4.1 
in WT and Kir5.1 KO mice (C) and a bar graph summarizes normalized band density of Kir4.1 (D). (E) 
Immunostaining of Kir4.1 in kidney from WT and Kir5.1 KO mice. The treatment for the kidney slides was 
identical. 
Fig. 7 Deletion of Nedd4-2 increases Kir4.1 expression. (A) A bar graph summarizes the results of 
experiments in which Ba2+-sensitive K currents of the DCT were measured at -60 mV from the WT and 
Ks-Nedd4-2 KO mice (n=6). (B) Western blots showed the expression of Kir4.1 and Kir5.1 in WT and Ks-
Nedd4-2 KO mice. A bar graph summarizes normalized band density of Kir4.1 and Ki5.1 (right panel). (C) 
Immunostaining of Kir4.1 in kidney from Ks-Nedd4-2 KO mice and WT control (without doxycycline 
treated). 
Fig. 8 A scheme illustrating the role of Kir5.1 as a binding partner in mediating Nedd4-2 E3 ligase 
dependent degradation of Kir4.1 in the DCT. A part of Kir5.1 sequence (from AA241 to 260) including 
TPVT motif is shown on the top.  
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Table 1 Primers used for genotyping. 
Kir4.1 Flox Forward TGATGTATCTCGATTGCTGC 
 
Reverse CCCTACTCAATGCTCTTAAC 
Nedd4-2 Flox Nedd4-2 Forward TGAGCTCATTGCTTCACTTCC 
 
Nedd4-2 Reverse TTCATGCTCGAAGCCTTAGC 
 
Flox Reverse TTTGTGAGGACAGCCTCTAGC 
Pax8 Forward CCATGTCTAGACTGGACAAGA 
 
Reverse CTCCAGGCCACATATGATTAG 
Cre Forward TCGCTGCATTACCGGTCGATGC 
 
Reverse CCATGAGTGAACGAACCTGGTCG 
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Table 2 Primers used for cloning WW domains of nedd4-2 (Uniprot_Q96PU5) and C-terminal 
peptide of Kir5.1 (Q9NPI9_ AA168-418). 
 
1WW  Forward 5'-ACGCGGATCCACCATGGGGTGGGAAGAAAAAGTGGAC 
( 81bp)  Reverse 5'-AGGGCTCGAGTTATGGTCTGTGCCACTGAGTG 
2WW  Forward 5'-ACGCGGATCCACCATGCTGCCTTCAGGCTGGGAAG 
( 90bp)   Reverse 5'-AGGGCTCGAGTTAAGGTCGAGTCCAAGTTGTG 
3WW  Forward 5'-ACGCGGATCCACCATGCCACCCGGCTGGGAAATG 
( 93bp)  Reverse 5'-AGGGCTCGAGTTACAAACGTGGATCTTCCCAG 
4WW  Forward 5'-ACGCGGATCCACCATGCCCCTTCCTCCTGGCTGG 
( 99bp)  Reverse 5'-AGGGCTCGAGTTACAGTCTTGGGTCTTCCCAC 
Kir5.1-C-ter Forward 5'-AAAACATATGACCATG GCCTTGGCCAAAATGGCAACTGCTC 
(756bp) Reverse 5'- AAAGGATCCCATTTGGGATTCTACAGAG 
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